Status:

ACTIVE_NOT_RECRUITING

The MARY-JANE Cannabis and Heart Rhythm Trial

Lead Sponsor:

University of California, San Francisco

Conditions:

Premature Atrial Contractions

Premature Ventricular Contractions

Eligibility:

All Genders

21+ years

Phase:

NA

Brief Summary

Despite recreational cannabis now being legal in 23 states, where more than 100 million Americans reside, studies on the actual health effects are limited. This study is a randomized trial, where each...

Detailed Description

This study is designed as a case-crossover randomized trial, where each participant will be instructed to consume or avoid inhaled cannabis on randomly assigned days during a 14-day monitoring period....

Eligibility Criteria

Inclusion

  • Are age 21 or older
  • Have a smartphone
  • Are able to use the Eureka mobile application and Mosio text messaging software
  • Have inhaled cannabis in the past month and on at least four different days in the same week in the past year
  • Are willing to consume and abstain from inhaled cannabis for no more than two consecutive days as instructed over the 14-day trial period
  • Are able to participate in a location where cannabis use would not break any established laws under any jurisdiction
  • Are able to self supply cannabis throughout the study duration

Exclusion

  • Currently pregnant or trying to get pregnant
  • Have a medical reason to avoid cannabis
  • Are unwilling to avoid all forms of cannabis consumption on days instructed to abstain from cannabis
  • Are currently taking anti-arrhythmic medications
  • Have a history of atrial fibrillation or heart failure
  • Have congenital heart disease
  • Have an implantable cardioverter-defibrillator or pacemaker
  • Have had a previous cardiac ablation procedure
  • Are currently taking insulin
  • Are unable to read or sign to provide informed consent

Key Trial Info

Start Date :

January 18 2024

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

November 1 2026

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT06021613

Start Date

January 18 2024

End Date

November 1 2026

Last Update

June 29 2025

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

UCSF Medical Center at Parnassus

San Francisco, California, United States, 94143

2

UCSF Medical Center at Mission Bay

San Francisco, California, United States, 94158